Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj.
An inbred strain of mice, NC, has been introduced as an animal model for atopic dermatitis because the mice develop dermatitis associated with severe scratch preceded by elevated serum IgE level when kept in conventional conditions. Although hypersensitivity to some environmental factors is suggested to cause dermatitis, the precise factor remains unclear. As the mice maintained under conventional conditions were often infected with fur mites, we investigated whether an infection of fur mites induces skin lesions in NC. Infection with the fur mites induced NC to develop skin lesions associated with highly elevated serum IgE, whereas no obvious skin lesions were observed in BALB/c and C57BL/6, and the elevation of serum IgE level was minimal in these two strains of mice. The role of the fur mites in the manifestation of skin lesions and IgE hyperproduction was confirmed by eliminating the fur mites by treatment with ivermectin. In addition, the existence of specific IgE antibody to Myocoptes musculinus antigen in the sera of mite-infested NC was detected by the antigen-induced histamine release from bone marrow-derived cultured mast cells after sensitization with the serum. These results suggest that continuous exposure to fur mite antigen is a potential factor in the development of dermatitis in NC. We provide a new model system of antigen-induced dermatitis for investigating the role of IgE in eliciting dermatitis.
Morita
E
E
Department of Dermatology, Hiroshima University School of Medicine, Japan.
Kaneko
S
S
Hiragun
T
T
Shindo
H
H
Tanaka
T
T
Furukawa
T
T
Nobukiyo
A
A
Yamamoto
S
S
D000818:Animals; D039741:Antigens, Dermatophagoides; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D003872:Dermatitis / Q000209:etiology* / Q000276:immunology / Q000469:parasitology; D005260:Female; D006023:Glycoproteins / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects; D007073:Immunoglobulin E / Q000096:biosynthesis* / Q000097:blood / Q000187:drug effects; D007306:Insecticides / Q000494:pharmacology; D007559:Ivermectin / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D008924:Mite Infestations / Q000150:complications*; D008925:Mites; D012867:Skin / Q000187:drug effects / Q000469:parasitology / Q000473:pathology; D013045:Species Specificity
D039741:Antigens, Dermatophagoides; D006023:Glycoproteins; D007306:Insecticides; D007073:Immunoglobulin E; D007559:Ivermectin